The next biggest markets for CROs Part 4: Poland


After the fall of the Iron Curtain more than 20 years ago, Poland emerged with Russia as an outsourcing hot spot in Eastern Europe, but the clinical market there was stagnant during the last decade.

Now, thanks to some recent government initiatives to boost clinical research, Poland is climbing back into the outsourcing spotlight. Four years ago, the Polish government lifted a tax block, allowing clinical research to be taxable in a client’s home country, rather than in Poland. The previous tax code comprised a confusing mix of tax classifications, some with built-in exemptions and others without.

Last year, the Polish clinical trial market exhibited 7% growth, according to a study by market research group PMR. Year-to-year expansion is expected to hover around 3% and 4% in 2012 and 2013, the study showed.

Still, the study reinforces the fact that Poland needs to undertake some reforms if it wants to broaden its appeal for clinical research.



For more information about the topics discussed at the World Vaccine Congress Washington, please click here >

See who is already attending >
Interested in attending? Don't miss out! Download the brochure to find out more >

For more updates on the vaccines industry, follow us on Twitter: @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Reply

Your email address will not be published. Required fields are marked *